Crescent Biopharma to Present at September Investor Conferences
Crescent Biopharma plans September 2026 fireside chats at Cantor and Morgan Stanley investor healthcare conferences, with webcasts and 90-day replays available.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Crescent Biopharma (CBIO)/b) will present at two September 2026 investor conferences via fireside chats in New York.Management is scheduled for the 2026 Cantor Global Healthcare Conference on Thursday, September 10, 2026 at 1:35 p.m. ET and the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026 at 5:35 p.m. ET. Live webcasts and 90-day replays will be available in the Investors section of the company website.
Details
News Market Reaction – CBIO
On Sep 3, the day this news came out, CBIO closed 10.03% above the previous close. Argus tracked a peak move of +13.8% during that session. Our momentum scanner recorded 33 alerts for this stock that day. Relative volume reached 10.1x the daily average during tracking.
Data tracked by StockTitan Argus for the Sep 3 session.
Key Figures
- Cantor presentation
- September 10, 2026 at 1:35 p.m. ET
- 2026 Cantor Global Healthcare Conference
- Morgan Stanley presentation
- September 14, 2026 at 5:35 p.m. ET
- Morgan Stanley 24th Annual Global Healthcare Conference
- Replay availability
- 90 days
- Webcast replay for each presentation
Historical Context
-
Equity inducement awards for one non-executive employee
-
Cash runway update and oncology pipeline progress
-
Equity inducement awards for two non-executive employees
-
Ordinary shares and pre-funded warrants issued in completed offering
-
Offering priced at $14.50 per ordinary share
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WALTHAM, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in September:
- 2026 Cantor Global Healthcare Conference, fireside chat on Thursday, September 10, 2026 at 1:35 p.m. ET in New York.
- Morgan Stanley 24th Annual Global Healthcare Conference, fireside chat on Monday, September 14, 2026 at 5:35 p.m. ET in New York.
A live webcast of each presentation will be available in the Investors section of the Company's website at https://investors.crescentbiopharma.com/events-presentations, and a replay will be accessible for 90 days.
About Crescent Biopharma
Crescent Biopharma’s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company’s clinical-stage pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates (ADCs). By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies as single agents and as part of combination regimens to treat a range of solid tumors. For more information, visit www.crescentbiopharma.com and follow the Company on LinkedIn and X.
Contacts
Investors
Amy Reilly
Chief Communications Officer
amy.reilly@crescentbiopharma.com
617-465-0586
Media
Jenna Poist
Director, Corporate Communications
jenna.poist@crescentbiopharma.com
781-671-5019
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.